Douglas J. Hughes Immunovant, Inc. (IMVT) insider trading activity

Douglas J. Hughes is Director of Immunovant, Inc.. Currently has a direct ownership of 120,773 shares of IMVT, which is worth approximately $3.32 Million. The most recent transaction as insider was on Dec 01, 2025, when has been sold 15,000 shares (Common Stock) at a price of $23.55 per share, resulting in proceeds of $353,250. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 121K

11.05% 3M change

0.99% 12M change

Total Value Held $3.32 Million

Douglas J. Hughes Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 01 2025	SELL Open market or private sale	$353,250 $23.55 p/Share	15,000 Reduced 11.05%	120,773 Common Stock
Apr 01 2025	BUY Grant, award, or other acquisition	-	16,188 Added 10.65%	135,773 Common Stock
Dec 02 2024	SELL Open market or private sale	$154,829 $28.54 p/Share	5,425 Reduced 4.34%	119,585 Common Stock
Apr 02 2024	BUY Grant, award, or other acquisition	-	11,255 Added 8.26%	125,010 Common Stock
Apr 12 2023	BUY Grant, award, or other acquisition	-	12,523 Added 9.92%	113,755 Common Stock
Aug 17 2022	BUY Grant, award, or other acquisition	-	21,059 Added 17.22%	101,232 Common Stock
Jan 10 2022	BUY Grant, award, or other acquisition	-	21,726 Added 21.32%	80,173 Common Stock

Aug 27 2021	BUY Open market or private purchase	$150,355 $8.24 p/Share	18,247 Added 23.79%	58,447 Common Stock
Mar 19 2021	BUY Grant, award, or other acquisition	-	15,500 Added 27.83%	40,200 Common Stock

Also insider at

EAR

Eargo, Inc. Healthcare

Director

DJH

Douglas J. Hughes

Director

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMVT shares.

Notify only if

Value

Insider Trading

Get notified when an Immunovant, Inc. insider buys or sells IMVT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Immunovant, Inc.

Track Activities on IMVT

Account